Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes-Reference-Cited by-同舟云学术

Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes

Published:2013-10-16 Issue:6 Volume:63 Page:1005-1013
ISSN:0017-5749
Container-title:Gut
language:en
Short-container-title:Gut

Author:

Manousou Pinelopi,Cholongitas Evangelos,Samonakis Dimitrios,Tsochatzis Emmanuel,Corbani Alice,Dhillon A P,Davidson Janice,Rodríguez-Perálvarez Manuel,Patch D,O'Beirne J,Thorburn D,Luong TuVinh,Rolles K,Davidson Brian,McCormick P A,Hayes Peter,Burroughs Andrew K

Publisher

BMJ

Subject

Gastroenterology

Reference41 articles.

1. Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy;Manousou;Liver Transpl,2009

2. Immunosuppression and donor age with respect to severity of HCV recurrence after liver transplantation;Samonakis;Liver Transpl,2005

3. Digital image analysis of liver collagen predicts clinical outcome of recurrent hepatitis C virus 1 year after liver transplantation;Manousou;Liver Transpl,2011

4. Digital image analysis of collagen assessment of progression of fibrosis in recurrent HCV after liver transplantation;Manousou;J. Hepatol,2013

5. Azathioprine in liver transplantation: a reevaluation of its use and a comparison with mycophenolate mofetil;Germani;Am J Transplant,2009

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Review of Liver Allograft Fibrosis and Steatosis: From Cause to Diagnosis;Transplantation Direct;2023-10-16

2. Immunosuppression, Compliance, and Tolerance After Orthotopic Liver Transplantation: State of the Art;Experimental and Clinical Transplantation;2022-03

3. Andrew K. Burroughs: a research hepatologist extraordinaire;Annals of Hepatology;2021-11

4. Immunosuppression in Liver Transplantation: State of the Art and Future Perspectives;Current Pharmaceutical Design;2020-08-31

5. Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients;Cochrane Database of Systematic Reviews;2018-04-09